Delamanid-D4
| Product Name | Delamanid-D4 |
|---|---|
| Alternate Names | Delamanid Stable Isotopes, Stable Isotopes of Delamanid |
| CAT No. | CS-CX-00753 |
| CAS No. | 681492-22-8 (Unlabeled) |
| Category | Stable Isotopes |
| Stock | IN-Stock |
| Mol. Wt. | 538.51 g/mol |
| Mol. For. | C₂₅H₂₁D₄F₃N₄O₆ |
| Hazardous | This is a Hazardous Compound |
| COA | View Sample COA |
| MSDS | View Sample MSDS |
| Parent API | Delamanid |
| Purity | 95% |
| Smileys | C[C@](CN1C2=NC([N+]([O-])=O)=C1)(O2)COC3=CC=C(N4C([2H])([2H])CC(OC5=CC=C(OC(F)(F)F)C=C5)CC4([2H])[2H])C=C3 |
| Controlled | No |
| Shipping | Free for purchase above 1000$ |
| Delivery | In-Stock, products will be dispatched within 24 hours via FedEx for USA, Europe, and other countries. |
| Return | Returns/replacement accepted if you are not satisfied with the quality of the product, (please send us an email with the reason/issues which are facing, within 15 days, after receipt of the product). |
| Ordering | Place your order online or by email sales@clearsynth.com |
Delamanid-D4 is a deuterated form of Delamanid, which is a medication used in combination with other drugs to treat tuberculosis (TB). The chemical formula for Delamanid-D4 is C14H6D4F6N4O2, and it is also known as Bedaquiline-D4. The deuterium atoms in Delamanid-D4 replace the hydrogen atoms in Delamanid, making it a heavier version of the original drug.
Delamanid-D4 acts by inhibiting the enzyme mycolic acid synthase, which is essential for the formation of the cell wall of the TB bacteria. This leads to the disruption of the bacterial cell wall, ultimately killing the bacteria. Delamanid-D4 is primarily used in the treatment of multidrug-resistant TB (MDR-TB), which is a type of TB that is resistant to the two most powerful anti-TB drugs, isoniazid and rifampicin.
The recommended dose of Delamanid-D4 is 400mg once daily, taken as a tablet with food. It is important to note that Delamanid-D4 should only be used under the supervision of a healthcare professional. Common side effects of Delamanid-D4 include nausea, vomiting, and abdominal pain.
In conclusion, Delamanid-D4 is a deuterated form of Delamanid used in combination with other drugs to treat multidrug-resistant TB. It works by inhibiting the enzyme mycolic acid synthase, ultimately killing the TB bacteria. Delamanid-D4 should only be used under the supervision of a healthcare professional and may cause side effects such as nausea, vomiting, and abdominal pain.
Get an Instant Quote
Related Compounds
Delamanid Metabolite DM-6705 -D4 |